Accelerating Obesity Drug Lead Optimization
Inspired by significant advancements in obesity drug development, this challenge focuses on building an AI-driven system to optimize lead compounds for metabolic disorders. Participants will create a multi-agent AI framework that simulates different stages of drug discovery, from target interaction prediction to ADMET property assessment, with the goal of identifying novel drug candidates or improving existing ones. The emphasis is on developing compounds with enhanced efficacy, reduced off-target effects, and favorable pharmacokinetic profiles. This project requires integrating computational chemistry techniques with advanced AI, including generative models for molecular design and multi-agent systems for iterative refinement. Candidates will develop a pipeline that screens virtual libraries, predicts protein-ligand binding affinities, assesses ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties, and recommends structural modifications. The outcome will be a refined set of lead compounds with improved predicted properties, showcasing the power of AI in accelerating drug discovery.
What you are building
The core problem, expected build, and operating context for this challenge.
Inspired by significant advancements in obesity drug development, this challenge focuses on building an AI-driven system to optimize lead compounds for metabolic disorders. Participants will create a multi-agent AI framework that simulates different stages of drug discovery, from target interaction prediction to ADMET property assessment, with the goal of identifying novel drug candidates or improving existing ones. The emphasis is on developing compounds with enhanced efficacy, reduced off-target effects, and favorable pharmacokinetic profiles. This project requires integrating computational chemistry techniques with advanced AI, including generative models for molecular design and multi-agent systems for iterative refinement. Candidates will develop a pipeline that screens virtual libraries, predicts protein-ligand binding affinities, assesses ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties, and recommends structural modifications. The outcome will be a refined set of lead compounds with improved predicted properties, showcasing the power of AI in accelerating drug discovery.
Shared data for this challenge
Review public datasets and any private uploads tied to your build.
What you should walk away with
Master the principles of lead optimization in drug discovery, including scaffold hopping, R-group enumeration, and property-guided design, with a focus on metabolic targets.
Implement a generative model (e.g., MolGPT, REINVENT, or a domain-adapted Transformer like StarCoder 2 for chemical scaffolds and optimization scripts) capable of proposing diverse and synthesizable chemical structures or modifications based on a given lead compound.
Design and orchestrate a multi-agent AI system using a framework like CAMEL (Communicative Agents for Metabolic Exploration and Lead optimization). Define roles for agents such as 'Synthesizer Agent', 'Pharmacology Agent', 'ADMET Agent', and 'Optimizing Agent' that communicate to iteratively refine molecular structures.
Build predictive models for key pharmacological properties, including protein-ligand binding affinity (e.g., using docking simulations or ML models trained on binding data) and crucial ADMET properties (e.g., Caco-2 permeability, CYP inhibition, hERG toxicity).
Integrate Pinecone as a high-performance vector database to store embeddings of millions of known compounds, generated leads, and their predicted properties, facilitating rapid similarity searches and retrieval for drug repurposing or scaffold identification.
Develop an automated workflow for evaluating the generated lead compounds, encompassing novelty assessment, synthetic accessibility scoring, and comprehensive multi-parameter optimization (MPO) against a set of predefined criteria for obesity treatment.
Deploy a system for visualizing molecular structures, their predicted interaction with target proteins (simulated), and their ADMET profiles to aid in decision-making for lead selection.
How this agent runs
Participants will submit their code, a detailed report on the multi-agent system architecture, the iterative optimization process, and the top 10 optimized lead compounds with their predicted properties. Evaluation wi...
Challenge input
JSON with 'target_protein_id': string, 'initial_lead_SMILES': string.
Agent execution
The configured agent processes the input under the challenge policy.
Evaluated output
JSON with 'agents_initialized': boolean, 'initial_dialogue_summary': string.
- Verifies that agents communicate effectively and roles are clearly defined and executed.
- Checks for iterative improvement in target properties across optimization steps.
- Ensures binding affinity and ADMET models are correctly integrated and yield plausible predictions.
- Best Binding Affinity target: -9.5
- Python execution harness
View technical recipe
Configured tools
No tool records are attached.
Evaluation contract
- The evaluation module defines the checks.
Recipe state
This is a preview. The configuration can change before the evaluation recipe is locked.
Run this agent on your dataset and AI stack
Bring your dataset, model providers, and success criteria. We will scope the right managed run for your team.
Scope a managed run[ok] Wrote CHALLENGE.md
[ok] Wrote .versalist.json
[ok] Wrote eval/examples.json
Requires VERSALIST_API_KEY. Works with any MCP-aware editor.
DocsFind another challenge
Jump to a random challenge when you want a fresh benchmark or a different problem space.